219 related articles for article (PubMed ID: 23583670)
1. Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample.
Guffanti G; Torri F; Rasmussen J; Clark AP; Lakatos A; Turner JA; Fallon JH; Saykin AJ; Weiner M; ; Vawter MP; Knowles JA; Potkin SG; Macciardi F
Genomics; 2013 Aug; 102(2):112-22. PubMed ID: 23583670
[TBL] [Abstract][Full Text] [Related]
2. Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study.
Swaminathan S; Shen L; Kim S; Inlow M; West JD; Faber KM; Foroud T; Mayeux R; Saykin AJ; ;
Curr Alzheimer Res; 2012 Sep; 9(7):801-14. PubMed ID: 22486522
[TBL] [Abstract][Full Text] [Related]
3. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.
Saykin AJ; Shen L; Yao X; Kim S; Nho K; Risacher SL; Ramanan VK; Foroud TM; Faber KM; Sarwar N; Munsie LM; Hu X; Soares HD; Potkin SG; Thompson PM; Kauwe JS; Kaddurah-Daouk R; Green RC; Toga AW; Weiner MW;
Alzheimers Dement; 2015 Jul; 11(7):792-814. PubMed ID: 26194313
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of genetic difference between mild cognitive impairment and Alzheimer's disease through genome-wide association study].
Bai Z; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):342-346. PubMed ID: 29896728
[TBL] [Abstract][Full Text] [Related]
5. Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.
Swaminathan S; Huentelman MJ; Corneveaux JJ; Myers AJ; Faber KM; Foroud T; Mayeux R; Shen L; Kim S; Turk M; Hardy J; Reiman EM; Saykin AJ;
PLoS One; 2012; 7(12):e50640. PubMed ID: 23227193
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
7. Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study.
Swaminathan S; Kim S; Shen L; Risacher SL; Foroud T; Pankratz N; Potkin SG; Huentelman MJ; Craig DW; Weiner MW; Saykin AJ; The Alzheimer's Disease Neuroimaging Initiative Adni
Int J Alzheimers Dis; 2011; 2011():729478. PubMed ID: 21660214
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide copy-number variation study of psychosis in Alzheimer's disease.
Zheng X; Demirci FY; Barmada MM; Richardson GA; Lopez OL; Sweet RA; Kamboh MI; Feingold E
Transl Psychiatry; 2015 Jun; 5(6):e574. PubMed ID: 26035058
[TBL] [Abstract][Full Text] [Related]
9. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.
Shen L; Kim S; Risacher SL; Nho K; Swaminathan S; West JD; Foroud T; Pankratz N; Moore JH; Sloan CD; Huentelman MJ; Craig DW; Dechairo BM; Potkin SG; Jack CR; Weiner MW; Saykin AJ;
Neuroimage; 2010 Nov; 53(3):1051-63. PubMed ID: 20100581
[TBL] [Abstract][Full Text] [Related]
10. A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk.
Chapman J; Rees E; Harold D; Ivanov D; Gerrish A; Sims R; Hollingworth P; Stretton A; ; Holmans P; Owen MJ; O'Donovan MC; Williams J; Kirov G
Hum Mol Genet; 2013 Feb; 22(4):816-24. PubMed ID: 23148125
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA;
BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks.
Ramanan VK; Kim S; Holohan K; Shen L; Nho K; Risacher SL; Foroud TM; Mukherjee S; Crane PK; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
Brain Imaging Behav; 2012 Dec; 6(4):634-48. PubMed ID: 22865056
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder.
Jarick I; Volckmar AL; Pütter C; Pechlivanis S; Nguyen TT; Dauvermann MR; Beck S; Albayrak Ö; Scherag S; Gilsbach S; Cichon S; Hoffmann P; Degenhardt F; Nöthen MM; Schreiber S; Wichmann HE; Jöckel KH; Heinrich J; Tiesler CM; Faraone SV; Walitza S; Sinzig J; Freitag C; Meyer J; Herpertz-Dahlmann B; Lehmkuhl G; Renner TJ; Warnke A; Romanos M; Lesch KP; Reif A; Schimmelmann BG; Hebebrand J; Scherag A; Hinney A
Mol Psychiatry; 2014 Jan; 19(1):115-21. PubMed ID: 23164820
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.
Szigeti K; Lal D; Li Y; Doody RS; Wilhelmsen K; Yan L; Liu S; Ma C;
J Alzheimers Dis; 2013; 33(2):517-23. PubMed ID: 23202439
[TBL] [Abstract][Full Text] [Related]
15. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation and neuroimaging measures in Alzheimer disease.
Biffi A; Anderson CD; Desikan RS; Sabuncu M; Cortellini L; Schmansky N; Salat D; Rosand J;
Arch Neurol; 2010 Jun; 67(6):677-85. PubMed ID: 20558387
[TBL] [Abstract][Full Text] [Related]
17. Multiple loci influencing hippocampal degeneration identified by genome scan.
Melville SA; Buros J; Parrado AR; Vardarajan B; Logue MW; Shen L; Risacher SL; Kim S; Jun G; DeCarli C; Lunetta KL; Baldwin CT; Saykin AJ; Farrer LA;
Ann Neurol; 2012 Jul; 72(1):65-75. PubMed ID: 22745009
[TBL] [Abstract][Full Text] [Related]
18. Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Shanghai Aging Study.
Xi J; Ding D; Zhao Q; Liang X; Zheng L; Guo Q; Hong Z; Fu H; Xu J; Xiao Q
Curr Alzheimer Res; 2020; 17(2):185-195. PubMed ID: 32183673
[TBL] [Abstract][Full Text] [Related]
19. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
[TBL] [Abstract][Full Text] [Related]
20. PIN-1 promoter polymorphisms in mild cognitive impairment and susceptibility to Alzheimer's disease: a preliminary report.
Arosio B; Segat L; Milanese M; Galimberti L; Calabresi C; Zanetti M; Trabattoni D; Annoni G; Crovella S; Vergani C
Aging Clin Exp Res; 2007 Oct; 19(5):406-9. PubMed ID: 18007120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
